HomeFinanceNVE (NVEC) Q2 2027 Earnings Call Transcript.

NVE (NVEC) Q2 2027 Earnings Call Transcript.

Logo of jester cap with thought bubble.

Image source: The Motley Fool.

DATE

Wed, Oct. 21, 2026

CALL PARTICIPANTS

  • President and Chief Executive Officer – Peter G. Eames
  • Principal Financial Officer – Daniel Nelson

TAKEAWAYS

  • Total Revenue — $5.83 million, representing an 8% decrease driven by a reduction in product sales.
  • Product Sales — $5.58 million, declining 9% due to a short-term inventory adjustment at a large medical device customer and a significant drop in defense sales.
  • Contract Research and Development Revenue — $259,420, increasing 25% reflecting progress made on existing contracts.
  • Net Income — $3.17 million, or $0.65 per diluted share, compared to $3.31 million in the prior year quarter.
  • Net Margin — 54%, increasing from the prior year because of a decrease in the effective tax rate.
  • Gross Margin — 78%, reflecting the company’s profitability profile in its core product lines.
  • Effective Tax Rate — 14%, down from 20% in the prior year quarter due to favorable tax law changes.
  • First-Half Total Revenue — $16.87 million, increasing 36% compared to the first six months of fiscal 2026.
  • First-Half Operating Cash Flow — $11.1 million, up from $8 million in the prior year period.
  • Distributor Sales — 67% growth, driven by strengthening industry conditions and strong demand for both new and legacy commercial products.
  • Defense Product Sales — 95% decrease, resulting from the inherent variability in government procurement cycles.
  • Second-Half Revenue Guidance — $16.87 million, with management expecting performance to be consistent with the first half of the fiscal year.
  • Cash and Marketable Securities — $44.4 million, up from $43.5 million as operating cash flow covered dividends and fixed asset purchases.
  • Tax Rate Guidance — 14% to 16%, expected to be maintained for at least the remainder of the fiscal year.
  • Quarterly Dividend — $1.00 per share, with the next payment scheduled for Nov. 30, 2026.
  • Accounts Receivable — $3.01 million, a 12% decrease resulting from the timing of customer payments.
  • Inventories — $6.86 million, down 3% due to increased product sales during the first half of the fiscal year.
  • Operating Margin — 55%, demonstrating high operational efficiency despite lower quarterly top-line results.
  • Average Selling Price — $1 to $2 per sensor, with management noting that precision motion applications in robotics may require tens of sensors per unit.
  • Selling, General, and Administrative Expenses — $630,314, increasing 44% primarily due to higher director option grant stock prices.
  • Research and Development Expenses — $727,345, decreasing 17% due to staff redeployment.

Need a quote from a Motley Fool analyst? Email [email protected]

RISKS

  • Nelson stated, “Defense product sales can be highly variable because of government procurement cycles,” explaining the sharp decline in that segment during the quarter.
  • Nelson stated, “Inventory adjustments by medical device customers can create short-term volatility for us,” addressing the primary cause for the quarterly product sales contraction.

SUMMARY

NVE Corporation (NVEC +1.00%) reported a second quarter revenue decline attributed to specific customer inventory timing and volatility in government defense procurement. Management noted that the decrease in medical device sales resulted from orders being pulled forward into the first quarter, causing a temporary disruption in the second quarter order flow. Despite the quarterly fluctuation, the company reported substantial growth for the first six months of the fiscal year and maintained strong margins. Strategic initiatives are focused on leveraging the recent capacity expansion to launch new products into high-growth markets, specifically targeting robotics, power conversion, and the industrial internet of things.

  • Peter G. Eames became President and CEO in August, while former CEO Daniel Baker transitioned to the role of Chairman.
  • The company launched a new wafer-level chip-scale sensor measuring 0.55 mm square, which is the smallest product in the company’s history.
  • A new family of seven gear sensors was released to detect motion and position for use in encoders and closed-loop servo systems in factory automation.
  • CEO Eames stated, “The spatial sensitivity that we are providing with those devices is unmatched in the industry,” regarding the company’s competitive advantage in robotics.
  • The Board of Directors was expanded from five to seven members to strengthen corporate governance following the election of Carolyn Valentine.
  • Management noted that they provide the highest isolation in the industry for 800-volt power conversion applications in data centers.

INDUSTRY GLOSSARY

  • Spintronics: A nanotechnology that uses electron spin rather than charge to acquire, store, and transmit information.
  • MRAM: Magnetoresistive Random Access Memory, a type of non-volatile memory that uses magnetic storage elements.
  • IIoT: Industrial Internet of Things, the integration of sensors and smart devices into industrial manufacturing processes.
  • Couplers: Devices that transmit data signals between circuits while maintaining electrical isolation between them.
  • Wafer-level chip-scale package: A packaging technology where the final package is nearly the same size as the integrated circuit die.
  • Isolators: Components that prevent unwanted DC and AC currents between two parts of a system while allowing signal transmission.
  • DC-to-DC converters: Electronic circuits that convert a source of direct current from one voltage level to another.

Full Conference Call Transcript

Operator: Good afternoon. And welcome to the NVE Corporation conference call for the quarter ended September 30, 2026.

Peter G. Eames: I am Peter G. Eames, NVE’s President and CEO. With me on the call is Daniel Nelson, our Principal Financial Officer. This call is being webcast live on YouTube and Google Meet and being recorded. Replay is available through our website, nve.com, our YouTube channel, youtube.com/nvecorporation. All participants are currently in a listen-only mode. After our presentation, there will be a question-and-answer session. After my opening comments, Daniel Nelson will present our financial results. Then I will cover the business. I will also cover the recent leadership transition and board expansion then we will open the call to questions. We issued our press release with summary financial results and filed our quarterly report on Form 10-Q in the past hour.

Following the lows of March. Links to the press release and 10 Q are available through our website, the SEC’s website, and X. Formerly known as Twitter. Please refer to the safe harbor statement on your screen.

Comments we may make that relate to future plans, events, financial results or performance are forward looking statements that are subject to certain risks and uncertainties, including among others such factors as our reliance on several large customers for a significant percentage of revenue uncertainties related to the economic environments and the industries we serve, uncertainties related to future sales and revenues as well as risk factors listed from time to time in our filings with the SEC including our annual report on Form 10 ks for the year ended 03/31/2026. Actual results could differ materially from the information provided and we undertake no obligation to update forward looking statements we may make.

We are pleased to report solid revenue and earnings for the quarter, driven by a 67% increase in distributor sales, Net margins increased to 54% due to a decrease in our effective tax rate. Daniel Nelson will cover the details of the financials. Daniel?

Daniel Nelson: Thanks, Peter. Total revenue for the quarter decreased 8% compared to the prior year quarter. The decrease was due to a 9% decrease in product sales partially offset by a 25% increase in contract R&D revenue. The decrease in product sales was due to a short-term inventory adjustment at 1 of our large medical device customers. And a 95% decrease in defense product sales. Inventory adjustments by medical device customers can create short-term auto volatility for us. Defense product sales can be highly variable because of government procurement cycles.

Looking forward, we expect medical device and defense sales to recover in the current quarter and we expect revenues in the second half of the fiscal year to be consistent with the first half. Aside from the short-term order flow adjustments in medical, we saw a 67% increase in distributor sales due to strengthening industry conditions and strong demand for our new and legacy commercial products. The increase in contract R&D revenue in the past quarter was due to progress on existing contracts.

Total operating expenses increased 4% for the second quarter of fiscal 2027 compared to the second quarter of fiscal 2026 due to a 44% increase in selling, general, and administrative expense partially offset by a 17% decrease in R&D expense. The decrease in R&D was due to staff and redeployment. The increase in SG&A was due to higher director option granted stock prices. Our effective tax rate, which is the provision for income taxes, as a percentage of income before taxes, decreased to 14% from 20% in the prior year quarter, primarily due to favorable tax law changes.

The decrease is consistent with our previous estimates we expect our effective tax rate to be between 14% and 16% for at least the remainder of the fiscal year. Net income for the second quarter of fiscal 2027 was $3.17 million or $0.65 per diluted share compared to $3.3 million or $0.68 per share in the prior year quarter. Our profitability metrics for the quarter remained strong. In addition to the 54% net margin Peter mentioned previously, gross margin was 78%. Operating margin was 55%, and pretax margin was 63%. For the first 6 months of fiscal 2027, total revenue was $16.9 million. Up 36% over the same period in fiscal 2026.

The increase in revenue was due to strong sales across our product portfolio as well as increases in both direct and distributor sales. Net income was $9.57 million or $1.97 per diluted share for the first 2 quarters of fiscal 2027. Turning to cash flow items. Cash flows from operations was $11.1 million for first 6 months of fiscal 2027 compared to $8 million for the first 6 months of fiscal 2026. Cash plus marketable securities increased from $43.5 million to $44.4 million as operating cash flow more than cover our dividends and purchases of fixed assets for the first half of the fiscal year. Receivables decreased 12% due to timing of customers’ payment.

Inventories decreased 3% due to increased product sales in the first half of the fiscal year. And we paid our $1.00 per share quarterly dividend the past quarter and declare another dividend to be paid at the end of November. Now I will turn the call back over to Peter Eames to cover the business.

See More

Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular